Pharmacokinetics, safety, and 48-week efficacy of oral raltegravir in HIV-1-indected children aged 2 through 18 years - Nachman, Sharon; Zheng, Nan; Acosta, Edward P.; Teppler, Hedy; Homony, Brenda; Graham, Bobbie; Fenton, Terence; Xu, Xia; Wenning, Larissa; Spector, Stephen A.; Frenkel, Lisa M.; Alvero, Carmelita; et al. (Clinical Infectious Diseases, 2014)